ChiCTR2200064328 版本V1.0 版本创建时间2022/10/02 23:11:45 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200064328 

最近更新日期:

Date of Last Refreshed on:

2022-10-02 23:11:33 

注册时间:

Date of Registration:

2022-10-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于暴露-损伤效应的环境应激物与血管稳态及重构的相关性研究

Public title:

Correlation of environmental stressors with vascular homeostasis and remodeling based on exposure-injury effect

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于暴露-损伤效应的环境应激物与血管稳态及重构的相关性研究

Scientific title:

Correlation of environmental stressors with vascular homeostasis and remodeling based on exposure-injury effect

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

毛琦 

研究负责人:

赵晓辉 

Applicant:

Qi Mao 

Study leader:

Xiaohui Zhao 

申请注册联系人电话:

Applicant telephone:

17384073687

研究负责人电话:

Study leader's
telephone:

13508332848

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

holygeneral1214@163.com

研究负责人电子邮件:

Study leader's E-mail:

doctorzhaoxiaohui@yahoo.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市新桥医院心内科

研究负责人通讯地址:

重庆市新桥医院心内科

Applicant address:

Department of Cardiology, Xinqiao Hospital, Chongqing

Study leader's address:

Department of Cardiology, Xinqiao Hospital, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆市新桥医院心内科

Applicant's institution:

Department of Cardiology, Xinqiao Hospital, Chongqing

研究负责人所在单位:

重庆市新桥医院心内科

Affiliation of the Leader:

Department of Cardiology, Xinqiao Hospital, Chongqing

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022-研第112-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军军医大学第二附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Second Affiliated Hospital of Army Medical University, PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2022-04-20 00:00:00

伦理委员会联系人:

胡岚岚

Contact Name of the ethic committee:

Lanlan Hu

伦理委员会联系地址:

重庆市沙坪坝区新桥正街183号新桥医院药学部3楼伦理委员会

Contact Address of the ethic committee:

Ethics Committee, 3rd Floor, Department of Pharmacy, Xinqiao Hospital, No. 183, Xinqiaozheng Street, Shapingba District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新桥医院

Primary sponsor:

Xinqiao Hospital

研究实施负责(组长)单位地址:

重庆市沙坪坝区新桥正街183号

Primary sponsor's address:

Xinqiao Street 183, Shapingba district, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

沙坪坝区

Country:

China

Province:

Chongqing

City:

Shapingba District

单位(医院):

新桥医院

具体地址:

重庆市沙坪坝区新桥正街183号

Institution
hospital:

Xinqiao Hospital

Address:

183 Xinqiao Street, Shapingba district, Chongqing, China

经费或物资来源:

自筹

Source(s) of funding:

Self-financing

研究疾病:

血管疾病  

Target disease:

vascular disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

探讨环境应激物暴露水平与血管稳态、重构及心血管不良事件的相关性  

Objectives of Study:

The study aims to investigate the correlation of environmental stressors exposure level with vascular homeostasis, remodeling, and adverse cardiovascular events

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 病历资料信息完整
2. 均行冠脉造影检查

Inclusion criteria

1. Complete medical records
2. All performed coronary angiography

排除标准:

1. 年龄小于18岁
2. 妊娠期及哺乳期的妇女
3. 有精神病史
4. 明确的感染
5. 恶性肿瘤
6. 自身免疫性疾病及造血系统疾病
7. 住院时处于严重创伤期或外科大手术围手术期
8. 任何原因不能配合研究或研究者认为不宜纳入本研究

Exclusion criteria:

1. Under 18 years old
2. Women who are pregnant and breastfeeding
3. history of mental illness
4. Definite infection
5. Malignant diseases
6. Autoimmune diseases and hematopoietic diseases
7. Hospitalized in severe trauma or perioperative period of major surgery
8. Unable to cooperate with the study for any reason or the researcher thinks it is not suitable to be included in this study

研究实施时间:

Study execute time:

From 2022-10-01 00:00:00 To 2024-10-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-10-01 00:00:00 To 2022-12-31 00:00:00

干预措施:

Interventions:

组别:

Case series

样本量:

1200

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

新桥医院 

单位级别:

三级甲等 

Institution
hospital:

Xinqiao Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

主要不良心血管事件

指标类型:

主要指标

Outcome:

major adverse cardiovascular events

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

静脉血

组织:

Sample Name:

venous blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究为观察性研究,不涉及随机化

Randomization Procedure (please state who generates the random number sequence and by what method):

This study is an observational study and randomization is not applicable

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

根据请求可向研究者索取该研究的原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Primary data for the study are available from the investigator upon request

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表和Resman

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form and Resman

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-10-02 23:11:33